{"schema_version":"secwatch.filing_event.v1","accession":"0001071739-22-000077","form_type":"8-K","ticker":"CNC","cik":"0001071739","company_name":"CENTENE CORP","filed_at":"2022-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.338338+00:00","generated_at":"2026-06-27T04:33:55.329491+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"CEO Michael Neidorff takes medical leave; James Dallas named Acting Chairman","bullets":["Michael Neidorff granted paid medical leave of absence as CEO, Chairman, and director effective Feb 23, 2022.","James Dallas appointed Acting Chairman; Office of Chairman (London, Layton, Asher, Bagley) to manage daily operations.","Board's CEO succession process ongoing, targeted for completion in Q2 2022.","Neidorff led Centene for 26 years, growing it to Fortune 24 with over $125B revenue."],"urls":{"canonical":"https://secwatch.observer/filing/0001071739-22-000077","json":"https://secwatch.observer/filing/0001071739-22-000077.json","markdown":"https://secwatch.observer/filing/0001071739-22-000077.md","text":"https://secwatch.observer/filing/0001071739-22-000077.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1071739/000107173922000077/0001071739-22-000077-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1071739/000107173922000077/cnc-20220223.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T04:33:55.329491+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"41462df75f","claim":"James Dallas was appointed as Acting Chairman at CENTENE CORP.","evidence_excerpt":"The Board also (i) appointed James Dallas as the Acting Chairman of the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1071739/000107173922000077/0001071739-22-000077-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed as Acting Chairman"},{"label":"Role","value":"Acting Chairman"}],"fact_type":"executive_change"},{"claim_id":"4975d2a62a","claim":"Michael Neidorff changed role as Chief Executive Officer, Chairman, and Director at CENTENE CORP.","evidence_excerpt":"On February 23, 2022, the Board of Directors (the “Board”) of Centene Corporation (the “Company”) approved a request from Michael Neidorff for a paid medical leave of absence from his roles as Chief Executive Officer, Chairman, and a director of the Company (the “Leave of Absence”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1071739/000107173922000077/0001071739-22-000077-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"granted medical leave of absence"},{"label":"Role","value":"Chief Executive Officer, Chairman, and Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}